MEFs. These findings demonstrate that FXR regulates adipocyte differentiation and function by regulating two counteracting pathways of adipocyte differentiation, the PPAR and Wnt/-catenin pathways.
The nuclear receptor Farnesoid X Receptor (FXR) is a transcription factor which belongs to the nuclear receptor superfamily that is endogenously activated by bile acids (BA) [1] . FXR was initially found to regulate BA metabolism and to protect the liver from the deleterious effect of excessive BA accumulation [2] [3] [4] . The phenotype of FXR-deficient (FXR -/-) mice further established a role for FXR in lipid metabolism [5] . Recently, FXR was shown to be implicated in the control of hepatic glucose metabolism and peripheral insulin sensitivity [6] [7] [8] [9] . FXR modulates the fastingrefeeding transition in mice [8] and genetic murine models of diabetes display an increased FXR expression [10] . While FXR-deficiency was associated with peripheral insulin resistance [6] [7] , activation of FXR by bile acids [6] or specific synthetic agonists [7] [9] conversely improves glucose homeostasis in rodent models of diabetes. Finally, FXR appears to be involved in the regulation of adaptive thermogenesis in response to fasting or cold exposure [11] .
The primary role of adipose tissue is to store energy in form of triglycerides (TG) in the adipocytes, which can be liberated as fatty acids upon energy requirement. Adipose tissue is also an endocrine organ secreting hormones involved in metabolic homeostasis [12] . Preadipocyte differentiation into mature adipocytes is a finely tuned process that is regulated by a complex network of transcription factors. In this cascade, the peroxisome proliferator-activated receptor- (PPAR) [13] and CAAT/enhancer-binding protein (C/EBP)  [14] act as key regulators. Early regulators of preadipocyte differentiation are other members of the CAAT/enhancer binding protein family, C/EBP and C/EBP [15] , which induce the expression of PPAR and C/EBP [16] . Amongst the extracellular signaling pathways that regulate adipogenesis is the Wnt pathway [17] . The non-canonical and canonical Wnt signaling pathways, being respectively -catenin-independent and -dependent, are negative regulators of adipogenesis [17] . In the absence of Wnt proteins, -catenin is localized in the cytoplasm in a protein complex containing Axin and adenomatous polyposis coli (APC) proteins which facilitate -catenin phosphorylation and its subsequent proteasomal degradation [18] . The binding of Wnt proteins to their receptors Frizzled (FZD) and low-density lipoprotein-receptor related protein-5 or -6 (LRP5/6) leads to -catenin protein stabilization. Hypophosphorylated -catenin protein translocates into the nucleus and activates its target genes [19] . The activation of Wnt/-catenin signalling leads to the repression of adipogenesis by blocking the induction of PPAR and C/EBP expression [20] . On the other hand, PPAR activation leads to proteasomal-dependent -catenin degradation by stimulating the activity of GSK3, a -catenin kinase, and by interacting with phospho--catenin itself [20] [21] [22]. A finely regulated balance between -catenin activity and PPAR expression is thus required for proper adipocyte differentiation [23] . We (7) and others (24) have shown that FXR is expressed in adipocyte where it modulates adipocyte differentiation [7] [24] . FXR expression was found to be decreased in adipose tissue of mouse models of dietary and genetic obesity [7] . FXR expression is induced during adipocyte differentiation in 3T3-L1 cells and mouse embryonic fibroblasts (MEFs) [7] [24] . MEFs isolated from FXR -/-mice (FXR -/-MEFs) display an impaired adipocyte differentiation with a delay in the expression of adipogenic genes and a decreased lipid droplet size [7] . Additionally, FXR activation in 3T3-L1 cells during adipocyte differentiation by specific synthetic agonists increases mRNA expression of adipogenic genes, as well as insulin signaling and insulin-stimulated glucose uptake [7] [24] . In the present study, we provide in vivo evidence that FXR was necessary for a full response to PPAR activation. [7] . MEFs were plated in 6-well plates at 300,000 cells/well. Adipocyte differentiation was initiated 2 days after confluence with AmnioMAX-C100 medium (Invitrogen), 7.5% AmnioMAX-C100 supplement, 7.5% fetal bovine serum (FBS), 0.5mM 3-isobutyl-1-methylxanthine (IBMX), 1µM dexamethasone, 5µg/ml insulin. From day 3-8, cells were incubated with AmnioMAX-C100 medium with 5µg/ml insulin and 1µM rosiglitazone. 4 , 20mM NaHCO 3 , 2mM Na Pyruvate, 10mM HEPES, 3% BSA, pH7.4) containing 1.5mg/ml collagenase A (Roche Diagnostic GmbH, Germany) for 1.5h in a shaking water bath at 37°C. After digestion, the mature adipocytes were separated from the stromavascular cells by centrifugation. The stromavascular pellet containing the preadipocytes was treated with erythrocyte lysis solution (154mmol/l NH 4 Cl, 10mmol/l KHCO 3 , 0.1mmol/l EDTA) for 5min at room temperature and centrifuged. The preadipocyte containing pellet was cultured in PromoCell® Preadipocyte Growth Medium (PromoCell® GmbH, Germany) at 37°C in a humidified 95% air and 5% CO 2 incubator. Cultures were grown to confluence (days (-2)). Two days after confluence (day 0), the medium was changed to Preadipocyte Differentiation Medium supplemented with 8µg/ml d-Biotin-4, 0.5µg/ml bovine insulin, 400ng/ml dexamethasone, 44µg/ml IBMX, 9ng/ml Lthyroxine. From day 3-8, the medium was changed to Adipocyte Nutrition Medium and was supplemented with rosiglitazone (1µM Real Time Quantitative Reverse Transcription-PCR-Total RNA was isolated from white adipose tissue using the acid guanidinium thiocyanate/phenol/chloroform method and from MEFs and differentiated preadipocytes using the Trizol reagent (Invitrogen), and subsequently reverse-transcribed using Moloney Murine Leukemia Virus (MMLV) (Applied Biosytems, Paris, France). cDNAs were quantified by quantitative polymerase chain reaction (Quantitative PCR) on a Mx4000 apparatus (Stratagene) using specific primers (Sup. table1). mRNA levels were subsequently normalized to those of cyclophilin. ΔCt was calculated as the difference between the Ct of the gene of interest and that of cyclophilin. Plasmid and Retrovirus Infection-The retrovirus was constructed using the FXRα3 mouse cDNA. The sequences of the primers used were: atacgcggatccatggtgatgagtttcaggg and ctctagaccctacacgtcactcagctgcgcata (the initiation (atg) and stop (tag) codons are underlined). The FXR coding sequence was cloned into the mammalian expression vector pBabe-Puro (Invitrogen) in BamHI and SalI sites. Human embryonic kidney 293T modified packaging cells (Ecotropic Phoenix) were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS and transiently transfected with a pBabe-puro-FXR chimera or a pBabe-puro vector alone as negative control. 48h after transfection, the viral supernatant was harvested and used to infect the MEFs. Selection of MEFs which had incorporated the retrovirus was done by adding puromycine to the medium for 1 week. Western Blot-Total cellular MEFs protein was extracted using a RIPA lysis buffer (50mM Tris-HCl, 150mM NaCl, 1.0% (v/v) NP-40, 0.5% (w/v) Sodium Deoxycholate, 1.0mM EDTA, 0.1% (w/v) SDS and 0.01% (w/v) sodium azide, pH:7.4). Protein concentration was determined by the Bradford method (BioRad protein assay). Protein samples were denatured by heating to 90°C in SDS-reducing buffer and resolved by electrophoresis on 10% SDS-polyacrylamide gels. After protein transfer, nitrocellulose membranes were incubated with a mouse monoclonal anti-β-catenin antibody (# 610153, BD Transduction laboratoriesTM) for 3h and HRP-conjugated secondary antibody (DAKO A/S, Denmark) for 1h. Proteins were then visualised by chemiluminescence using an ECL detection kit (Amersham Biosciences, Orsay, France). Adipocyte Size Determination-Inguinal adipose tissue was fixed in 4% neutral buffered paraformaldehyde, embedded in paraffin, cut into 7-µm sections, and stained with hematoxylin. Cell size was determined using ImageJ software (Freeware; Rasband WS. Image J, US National Institutes of Health, Bethesda, Maryland, http://rsb.info.nih.gov/ij/). Microarray Analysis-Total RNA was prepared from epididymal adipose tissue of FXR +/+ and FXR -/-mice and the subsequent steps were performed as described elsewhere [25] . Affymetrix raw data were normalized using the RMA algorithm to obtain expression values in log2 [26] . Log2-transformed expression values were fitted to a linear model according to Limma package (http://www.bioconductor.orf) methods. A model was established in order to identify probesets significantly differentially expressed between FXR +/+ and FXR -/-mice. False discovery rate (FDR) correction was applied to take into account multiple testing hypotheses. Selection of relevant probe sets was based on a mean log2-expression value greater than 6.12 in a least one of the two compared conditions, a p-value < 10 -5 and an absolute fold change value of 1.5. Function of all clustering of regulated genes was performed by Ingenuity Pathway Analysis (www.ingenuity.com). Statistical Analysis-Statistical significance was analyzed using the unpaired Student's t test. All values are reported as means ± S.D. Values with p<0.05 were considered significant.
RESULTS

FXR-deficiency results in a partial resistance to PPAR activation in adipose tissue in vivo.
To explore whether the FXR and PPAR pathways interact in vivo, genetically obese (ob/ob) FXR -/-and FXR +/+ mice were treated with rosiglitazone (10mg/kg/bw) for 21 days. As a positive control of in vivo PPAR activation [27] , mice from both genotypes displayed a comparable increase of brown adipose tissue mass (Fig.1A) , a tissue that does not express FXR [11] [28] . As expected [7] Fig.2A) . Whereas the induction of other PPAR-target genes (CD36 and aP2) were also reduced in FXR -/-mice, the expression of adipogenic genes, such as C/EBP and C/EBP, were induced to the same level in both genotypes, and PPAR expression itself was not modified (Fig.2B ). Most interestingly, the induction of genes involved in lipid droplet formation, such as perilipin, ADRP and FSP-27 by rosiglitazone was totally abolished in FXR -/-compared to FXR +/+ mice, whereas S3-12 expression was not affected (Fig.2C ). These data demonstrate that FXR is necessary to ensure the full response to PPAR activation in adipose tissue.
FXR-deficiency results in an impaired responsiveness to PPAR activation in mouse embryonic fibroblasts (MEFs) in vitro.
To study whether FXR modulates adipocyte PPAR responsiveness in a cell-autonomous manner, mouse embryonic fibroblasts (MEFs) were isolated from FXR +/+ and FXR -/-embryos and differentiated into adipocytes with or without rosiglitazone and the expression of adipocyte differentiation markers was measured. As expected [7] , FXR -/-MEFs were resistant to adipocyte differentiation with a lower expression of C/EBP, PPAR and aP2 at day 4 of differentiation in the absence of rosiglitazone (Fig.3) . Upon PPAR activation the induction of C/EBP, PPAR and aP2 following rosiglitazone treatment was drastically reduced at day 4, and to a lesser extent at day 8, in FXR -/-compared to FXR +/+ MEFs (Fig.3) . These results show that FXR (Fig.4A) . Moreover, PPAR activated FXR -/-MEFs also exhibited an abnormal morphology with lipid droplets of smaller size (Fig.4B) . Accordingly, rosiglitazone-treated FXR -/-MEFs showed decreased expression of several lipid droplet genes at day 4, such as perilipin, ADRP, S3-12, three members of the PAT protein family [30] , and FSP-27 [31] , a member of the recently identified CIDE protein family (Fig.4C) . While perilipin gene expression did not differ between the two genotypes at day 8, ADRP and S3-12 gene expression was still significantly reduced (Fig.4C) (Fig.5B) . This phenotype was associated with a transiently reduced expression of the perilipin and FSP-27 genes at day 4, while ADRP and S3-12 gene expression was not affected (Fig.5C) . Surprisingly, FSP-27 mRNA levels were found to be increased at day 8 in FXR -/-adipocytes. Altogether, these results show that FXR -/-preadipocytes display altered adipocyte differentiation even when PPAR is activated.
Re-introduction of FXR in FXR -/-MEFs restores the expression of adipogenic and lipid droplet genes and increases the number of differentiated adipocyte clusters.
To determine whether the altered adipocyte differentiation observed in rosiglitazone-treated FXR -/-MEFs was strictly FXR-dependent, FXR was exogenously (re-)expressed in FXR -/-and FXR +/+ MEFs using a retrovirus encoding FXR3, which, together with FXR4, is expressed in MEF cells (data not shown). Infected cells were subsequently subjected to adipogenic differentiation in the presence of rosiglitazone. Retroviral infection led to a pronounced mRNA expression of FXR3 in FXR -/-MEFs during adipocyte differentiation, with a 3-fold higher expression at day 8 compared to FXR +/+ MEFs infected with empty retrovirus (data not shown). Importantly, re-introduction of FXR resulted in an increased number of differentiated adipocyte clusters (Fig.6A ) and a restoration of PPAR and aP2 expression at day 8, whereas neither the expression of C/EBP nor C/EBP was affected in FXR -/-MEFs (Fig.6B) . Moreover, the expression of all lipid droplet genes was significantly increased at day 8 (Fig.6C) (data not shown) . One of those identified is the Wnt/β-catenin signaling pathway known to inhibit adipocyte differentiation at least in part by inhibiting PPAR activity [19] . Indeed, mRNA levels of -catenin were increased in adipose tissue of FXR -/-vs FXR +/+ obese mice (Fig.7A ). In accordance with an increased Wnt/-catenin signaling, mRNA levels of LRP5 and Axin2 [18] , both target genes and components of the Wnt/-catenin pathway, and the target genes cyclin D1 and c-Myc (Fig.7B) . In parallel, western blot analysis showed that -catenin protein expression was higher in FXR -/-MEFs with a peak at day 4 compared to FXR +/+ MEFs (Fig.7C ). In accordance with an increased Wnt/-catenin signaling, the expression of LRP5, Axin2, cyclin D1 and c-Myc, four target genes of this pathway, was increased in FXR -/-compared to FXR +/+ MEFs (Fig.7D) . Moreover, restoration of FXR expression in FXR -/-MEFs using the FXR3 encoding retrovirus resulted in a decrease of β-catenin protein expression (Fig.  7E ) along with the improvement of adipocyte differentiation (Fig.6B) . Moreover, mRNA expression of the Wnt/-catenin pathway genes c-Myc, Axin2 and LRP5 decreased upon FXR reintroduction in FXR -/-MEFs (Fig.7E ).
To further assess whether the anti-adipogenic effect of FXR-deficiency is mediated by the activation of the Wnt/β-catenin signaling pathway, we investigated whether the secreted Wnt antagonist sFRP1 could reverse this effect. The elevated β-catenin protein expression in FXR -/-compared to FXR +/+ MEFs was reduced upon incubation with recombinant sFRP1 protein (Fig.8A) . Concomitantly, sFRP1 treatment of FXR -/-MEFs increased the expression of adipogenic markers, such as PPARγ and aP2 (Fig.8B ). These results demonstrate that the Wnt/-catenin pathway, which inhibits adipocyte differentiation and PPAR function, is activated in FXR-deficient adipocytes in vivo and in vitro and that restoration of FXR expression inhibits the Wnt signaling pathway. MEFs exhibited an over-activation of the Wnt/β-catenin signaling pathway, an inhibitor of adipocyte differentiation and PPAR function. These results demonstrate that FXR is critical for full adipocyte differentiation by promoting PPARγ activation and interfering with the Wnt/β-catenin signaling pathways. Our study shows that FXR-deficiency led to impaired adipocyte differentiation of MEFs, as well as preadipocytes isolated from the stromal fraction of FXR -/-adipose tissue, with a clear alteration of lipid droplet gene expression after differentiation in the presence of rosiglitazone. This alteration of mRNA expression in FXR -/-cells was already detectable at day 2 and 4, while the functional consequences reflected in lipid droplet morphology were observed later at day 8 of differentiation. This alteration of adipocyte differentiation induced by rosiglitazone was strictly FXR-dependent since FXR re-introduction improved differentiation of FXR -/-MEFs with an increased expression of adipogenic markers, such as PPARγ and aP2, and an increased number of differentiated cell clusters. Intriguingly, C/EBPα and C/EBPβ mRNA expression was not restored. We have currently no explanation for the lack of response of these two genes. Rosiglitazone-treated FXR -/-MEFs displayed an alteration of triglyceride storage that was correlated with a combination of a decrease of de novo lipogenesis and an increase of lipolysis. In parallel, the expression of lipogenic genes was decreased in FXR -/-MEFs (data not shown). This result is in agreement with those obtained in the 3T3-L1 cell line showing an increase of lipogenic gene expression after treatment with FXR agonists [24] . FXR -/-MEFs exhibited an increase of both basal and β-adrenergically-induced lipolysis. However, the extent of β-adrenergicallymediated induction was similar between FXR -/-and FXR +/+ MEFs suggesting that downstream pathways are not influenced by FXR. However, the expression of lipid droplet genes such as perilipin, ADRP, S3-12 and FSP-27, which play a role in lipid droplet formation and lipolysis, is altered even after PPARγ activation. Since, FXR -/-MEFs and preadipocytes present a decreased lipid droplet size, it would be interesting to determine the localisation of the ATGL and HSL proteins before and after β-adrenergic stimulation. Indeed, a recent study proposes that these two enzymes are preferentially associated with small lipid droplets [34] , and thus could contribute to the increase of lipolysis in FXR [38] . sFRP5 mRNA levels correlate with adiposity [39] . Thus, the observed decrease of sFRP5 mRNA expression is in agreement with the description of lower adipose tissue mass in FXR -/-mice [7] . Moreover, the expression of sFRP1, which, when over-expressed, induces spontaneous adipocyte differentiation [40] , was decreased in FXR -/-MEFs. mRNA levels of sFRP1 and sFRP5 were decreased respectively at day 2 and day 1 of MEFs differentiation, which correlates with the increased β-catenin protein levels especially at day 4 of FXR [42] . In summary, FXR is necessary for a proper response to PPARγ activation, suggesting a cross-talk between FXR and PPARγ. Moreover, FXR contributes to the induction of adipocyte differentiation by interfering with the Wnt/β-catenin signaling pathway. These results identify a critical role for FXR in adipose tissue to ensure the accurate and complete course of adipocyte differentiation. 
DISCUSSION
